Related Experiment Video
Updated: Jun 17, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage
Boris Leithäuser1, Jai-Wun Park
1Asklepios General Hospital Harburg, 1st Medical Department, Cardiology, Intensive Care Medicine, Hamburg, Germany.
Insights
Atrial fibrillation increases stroke risk, often due to clots from the left atrial appendage. Anticoagulation is effective but risky, leading to interest in left atrial appendage exclusion for stroke prevention.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Atrial fibrillation is a common arrhythmia causing significant morbidity and mortality from cardioembolic stroke.
- The left atrial appendage is a primary site for thrombus formation in non-valvular atrial fibrillation.
- Blood stasis in the left atrial appendage contributes to thrombosis, though other factors are involved.
Purpose of the Study:
- To review the pathophysiology of cardioembolic stroke in atrial fibrillation.
- To critically evaluate current stroke prevention strategies, particularly anticoagulation.
- To explore left atrial appendage exclusion as an alternative prophylaxis.
Main Methods:
- Literature review of atrial fibrillation pathophysiology.
- Analysis of current anticoagulation therapies (e.g., warfarin).
- Discussion of left atrial appendage exclusion techniques.
Main Results:
- Oral anticoagulation with vitamin-K antagonists is the most effective stroke prophylaxis.
- Anticoagulation is often contraindicated in the elderly due to bleeding risks.
- Left atrial appendage exclusion presents a considerable alternative for stroke prevention.
Conclusions:
- Understanding cardioembolic stroke pathophysiology is crucial for effective prevention.
- Limitations of current anticoagulation necessitate alternative strategies.
- Left atrial appendage exclusion offers a promising alternative for stroke prophylaxis in select atrial fibrillation patients.
Abstract:
Atrial fibrillation is the most common cardiac arrhythmias, and a major cause of morbidity and mortality due to cardioembolic stroke. The left atrial appendage is the major site of thrombus formation in non-valvular atrial fibrillation. Loss of atrial systole in atrial fibrillation and increased relative risk of associated stroke point strongly toward a role for stasis of blood in left atrial thrombosis, although thrombus formation is multifactorial, and much more than blood flow irregularities are implicated. Oral anticoagulation with vitamin-K-antagonists is currently the most effective prophylaxis for stroke in atrial fibrillation. Unfortunately, this treatment is often contraindicated, particularly in the elderly, in whom risk of stroke is high. Moreover, given the risk of major bleeding, there is reason to be skeptical of the net benefit when warfarin is used in those patients. This work reviews the pathophysiology of cardioembolic stroke and critically spotlights the current status of preventive anticoagulation therapy. Various techniques to exclude the left atrial appendage from circulation were discussed as a considerable alternative for stroke prophylaxis.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Aortic Regurgitation III: Medical Management

